A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation

NCT02333513 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Recurrent High-grade Glioma

Interventions

DRUG: Lomustine/Vincristine/Procarbazine

Sponsor

Hebei Yanda Hospital

Collaborators

[object Object]